Home Clinical Topics FDA approves new MS drug

FDA approves new MS drug

Author(s):

On Sept. 12, the U.S. Food and Drug Administration (FDA) approved Aubagio (teriflunomide), a once-a-day tablet for the treatment of adults with relapsing forms of multiple sclerosis (MS). Read more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here